Senestech, Inc. (NASDAQ:SNES) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.

According to Zacks, “SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company’s fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. “

Shares of Senestech (SNES) traded up 1.19% on Tuesday, hitting $1.70. 6,920 shares of the company traded hands. The stock’s 50-day moving average price is $1.94 and its 200-day moving average price is $1.94. Senestech has a 12 month low of $1.54 and a 12 month high of $10.69. The company’s market capitalization is $17.55 million.

Senestech (NASDAQ:SNES) last released its quarterly earnings results on Thursday, August 10th. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.07). The company had revenue of $0.01 million for the quarter, compared to analysts’ expectations of $0.10 million. On average, equities analysts predict that Senestech will post ($1.30) earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This story was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another website, it was illegally copied and reposted in violation of international trademark and copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/09/28/senestech-inc-snes-stock-rating-upgraded-by-zacks-investment-research.html.

In other Senestech news, Director Julia Ann Williams purchased 10,000 shares of Senestech stock in a transaction that occurred on Wednesday, July 26th. The stock was purchased at an average price of $3.21 per share, for a total transaction of $32,100.00. Following the transaction, the director now directly owns 11,950 shares in the company, valued at $38,359.50. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Andrew Altman purchased 20,000 shares of Senestech stock in a transaction that occurred on Friday, August 18th. The stock was acquired at an average price of $2.77 per share, with a total value of $55,400.00. Following the transaction, the chief operating officer now owns 2,600 shares in the company, valued at $7,202. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 54,100 shares of company stock valued at $155,730 and sold 19,411 shares valued at $46,073. 27.40% of the stock is owned by corporate insiders.

A hedge fund recently bought a new stake in Senestech stock. White Pine Capital LLC purchased a new stake in Senestech, Inc. (NASDAQ:SNES) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 19,250 shares of the company’s stock, valued at approximately $110,000. White Pine Capital LLC owned about 0.19% of Senestech at the end of the most recent reporting period. 15.34% of the stock is owned by hedge funds and other institutional investors.

About Senestech

SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.

Receive News & Stock Ratings for Senestech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech Inc. and related stocks with our FREE daily email newsletter.